RNS Number : 9741W
Synectics PLC
24 April 2019
 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

24 April 2019

 

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, has been notified that the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased on 23 April 2019 6,205 ordinary shares of 20 pence each in the Company ("Shares") at £2.01 per Share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 31 March 2019.

 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of Shares for ESAP purposes was the price per Share on the date of purchase.

 

As a result of these purchases, the Company has been notified that Paul Webb, Chief Executive Director, has acquired an interest in 448 Shares and that Greg Alcorn, a PDMR of the Company, has acquired an interest in 448 Shares.

 

Following this purchase by the ESAP, the interests of Paul Webb and Greg Alcorn in Shares are as follows:

 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

52,115

247,371

299,486

1.68%

Greg Alcorn

-

11,847

11,847

0.07%

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

Tel: +44(0) 114 255 2509

 

Stockdale Securities

Tom Griffiths / Henry Willcocks

Tel: +44 (0) 20 7601 6100


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAFLLAAKNEFF